Arecor Therapeutics (AREC) Stock Chart & Stock Price History GBX 48.64 +0.64 (+1.33%) As of 07/11/2025 10:18 AM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock Arecor Therapeutics Stock Price Performance The Arecor Therapeutics (AREC) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 54.11%, with a year-to-date return of -34.05%. In the past month, the stock has increased 13.12%, reflecting recent market activity. As of the latest close, Arecor Therapeutics traded at GBX 48.64 with a market cap of £18.37 million and volume of 28,474 shares. Receive AREC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Arecor Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+0.50%1 Month Performance+13.12%3 Month Performance+28.00%Year-To-Date Performance-34.05%1 Year Performance-54.11% AREC Stock Chart for Monday, July, 14, 2025 AREC Chart by TradingView Arecor Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/11/2025GBX 48.40GBX 48.64+0.50%GBX 48.64GBX 4828,474 shs£18.37 million07/10/2025GBX 48.40GBX 48.40GBX 48.40GBX 47.503,088 shs£18.27 million07/09/2025GBX 47.67GBX 48.40+1.53%GBX 48.40GBX 47.501,446 shs£18.27 million07/08/2025GBX 44GBX 47.67+8.34%GBX 47.70GBX 45553,861 shs£18.00 million07/07/2025GBX 44.50GBX 44-1.12%GBX 46.87GBX 44356,977 shs£16.61 million07/04/2025GBX 43.17GBX 43.17GBX 43.50GBX 43.1775,000 shs£16.30 million07/03/2025GBX 43.18GBX 43.17-0.02%GBX 43.50GBX 43.1775,000 shs£16.30 million07/02/2025GBX 43.18GBX 43.18GBX 43.18GBX 42.023,490 shs£16.30 million07/01/2025GBX 42.30GBX 43.18+2.08%GBX 45GBX 422,646 shs£16.30 million06/30/2025GBX 42.30GBX 42.30GBX 43.50GBX 42.302,352 shs£15.97 million Get the Latest News and Ratings for AREC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Arecor Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 06/27/2025GBX 42GBX 42.30+0.71%GBX 45GBX 42.3051 shs£15.97 million06/26/2025GBX 42.30GBX 42-0.71%GBX 42.30GBX 422,173 shs£15.86 million06/25/2025GBX 42.30GBX 42.30GBX 43.50GBX 42.301,000 shs£15.97 million06/24/2025GBX 42GBX 42.30+0.71%GBX 43.50GBX 42.301,000 shs£15.97 million06/23/2025GBX 42.30GBX 42-0.71%GBX 43.70GBX 4210,896 shs£15.86 million06/20/2025GBX 42.40GBX 42.30-0.24%GBX 43.50GBX 42.30549 shs£15.97 million06/19/2025GBX 42.50GBX 42.40-0.24%GBX 42.40GBX 414,377 shs£16.01 million06/18/2025GBX 42.50GBX 42.50GBX 43.50GBX 42.0319,529 shs£16.05 million06/17/2025GBX 42.03GBX 42.50+1.12%GBX 43.50GBX 42.0314,284 shs£16.05 million06/16/2025GBX 43GBX 42.03-2.26%GBX 43.50GBX 42.032,220 shs£15.87 million06/13/2025GBX 43.26GBX 43-0.60%GBX 45GBX 42.0322,689 shs£16.24 million Related Companies SkinBioTherapeutics Stock Price Chart Sareum Stock Price Chart Tissue Regenix Group Stock Price Chart Futura Medical Stock Price Chart Poolbeg Pharma Stock Price Chart OptiBiotix Health Stock Price Chart ImmuPharma Stock Price Chart Synairgen Stock Price Chart IXICO Stock Price Chart Aptamer Group Stock Price Chart Receive AREC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Arecor Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (LON:AREC) was last updated on 7/14/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredA new rule goes live in July — and the banks are quietly cashing inA major change is quietly going into effect this July — and Wall Street is already positioning for it. Big ...American Alternative | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredTrump’s biggest move, misreportedThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arecor Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Arecor Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
